2025 – Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid
Omar El Khalili, Collins Ambe Chenwi, Daniele Spalletta, Greta Marchegiani, Luca Carioti, Hossein Eizadi Moghadam, Ada Bertoli, Vincenzo Spagnuolo, Maria Mercedes Santoro, Francesca Ceccherini-Silberstein and Maria Concetta Bellocchi Journal of Medical Virology First published: 24 December 2025 https://doi.org/10.1002/jmv.70773
2025 – Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study
Romina Salpini, Lorenzo Piermatteo, Gian Paolo Caviglia, Ada Bertoli, Maurizia Rossana Brunetto, Bianca Bruzzone, Annapaola Callegaro, Cinzia Caudai, Daniela Cavallone, Luchino Chessa, Fernando Coghe, Nicola Coppola, Nunzia Cuomo, Stefano D’Anna, Mariantonietta Di Stefano, Floriana Facchetti, Claudio Farina, Donatella Ferraro, Elisa Franchin, Daniela Francisci, Silvia Galli, Anna Rosa Garbuglia, William Gennari, Valeria Ghisetti, Pietro Lampertico, Sergio Lo Caputo, Nadia Marascio, Stefano Menzo, Valeria Micheli, Grazia Anna Niro, Antonella Olivero, Pierpaolo Paba, Concetta Ilenia Palermo, Orazio Palmieri, Stefania Paolucci, Mariantonietta Pisaturo, Teresa Pollicino, Giuseppina Raffa, Teresa Santantonio, Giulia Torre, Ombretta Turriziani, Sergio Uzzau, Sara Colonia Uceda Renteria, Marialinda Vatteroni, Maurizio […]
Viromarkers at HIV&Hep 2025!
Many Viromarkers partners in Barcelona for the 23rd European Meeting on HIV & Hepatitis! Amongst them were EuResist, the University of Siena, University of Rome Tor Vergata, the Karolinska Institutet and MIB GmbH! Lorenzo Piermatteo and Stefano D’Anna from the University of Rome Tor Vergata presented “A High Degree of Genetic Variability Characterises HDV Sub-Genotypes 1 […]
Viromarkers at ICAR 2025!
EuResist, the University of Siena, the University of Rome Tor Vergata, and ASST Santi Paolo e Carlo, all members of the Viromarkers consortium, came together in Padua for the 17th edition of ICAR, the Italian Conference on AIDS and Antiviral Research. Lorenzo Piermatteo and Stefano D’Anna, from the University of Rome Tor Vergata, presented “An […]
Viromarkers at AREVIR 2025!
Viromarkers had a dedicated session, in collaboration with EuCARE, at this year’s AREVIR meeting! Amongst our speakers were Francesca Incardona, Maurizio Zazzi, Valentina Svicher, Francesca Ceccherini Silberstein, Martin Pirkl, and Gibran Horemheb Rubio Quintanares.
Viromarkers at EASL 2025!
Viromarkers presented its first poster! Lorenzo Piermatteo from the University of Rome Tor Vergata presented “In HDV sub-genotypes 1, the high degree of genetic variability can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity” at EASL 2025. The rest of our consortium was also highly involved in the conference, […]
Viromarkers/EuCARE session at AREVIR
We are happy to participate at AREVIR, on the 9th and 10th of May in Cologne. Viromarkers will have its own session, shared with EuCARE where we will discuss our major ongoing activities and objectives. AGENDA
Official kickoff in Rome
On the 3rd and 4th of April the consortium came together in Rome for the official kickoff of the project! Lively scientific discussions and a beautiful environment in Rome collaboration.
Kickoff in Rome
Official project kickoff on the 3rd and 4th of April 2025 in Rome! A valuable opportunity to strengthen collaboration, and align on key objectives and activities. AGENDA Gallery
Start of VIROMARKERS!
Viromarkers started! We are excited to begin on this journey of healthcare innovation.